A recent study by d'Alessandro et al. revealed antifibrotic therapy preserved fibrosis progression stabilizing Tfh cells in IPF patients after 1 year of treatment, also confirmed by IL‐4 distribution in these patients. The gene discussed is IL4; the disease is idiopathic pulmonary fibrosis.